QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

LIVN

QT75LivaNova PLC
NASDAQ·Healthcare·Medical - Devices·UK
Latest market price
78.50
+0.00%
OverviewShort InterestFilings
LIVNQT75LivaNova PLC·NASDAQ
OverviewShort InterestFilings
78.50+0.00%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E40.08EPS (ttm)1.96
Insider Own1.15%
Shs Outstand54.93M
Perf Week-1.80%
Market Cap4.31BForward P/E16.95EPS next Y4.63Insider Trans0.41%Shs Float-Perf Month7.65%
Enterprise Value4.11BPEG0.33EPS next Q1.08Inst Own-Short Float-Perf Quarter23.56%
Income107.81MP/S3.01EPS this Y116.80%Inst Trans-Short Ratio-Perf Half Y24.45%
Sales1.43BP/B3.54EPS next Y9.00%ROA4.26%Short Interest-Perf YTD27.58%
Book/sh22.05P/C17.48EPS next 5Y20.57%ROE9.13%52W High80.96 -3.04%Perf Year77.00%
Cash/sh9.83P/FCF26.77EPS past 3/5Y-ROIC10.19%52W Low41.02 91.37%Perf 3Y-
Dividend Est.-EV/EBITDA19.05Sales past 3/5Y10.74% 8.25%Gross Margin67.57%Volatility1.87% 2.43%Perf 5Y-
Dividend TTM-EV/Sales2.87EPS Y/Y TTM244.83%Oper. Margin14.16%ATR (14)2.56Perf 10Y-
Dividend Ex-Date-Quick Ratio1.11Sales Y/Y TTM14.45%Profit Margin7.47%RSI (14)63.29Recom2.17
Dividend Gr. 3/5Y-Current Ratio1.33EPS Q/Q11.36%SMA203.70%Beta1.20Target Price79.67
Payout0.00%Debt/Eq0.28Sales Q/Q14.20%SMA5012.23%Rel Volume1.76Prev Close78.50
Employees2,900LT Debt/Eq0.37EarningsAug 05SMA20025.43%Avg Volume809.72KPrice78.50
IPO DateOct 19, 2015Option/ShortYes / YesEPS/Sales Surpr.15.29% 4.62%Net Debt/EBITDA-0.95Volume1,426,485Change0.00%
Analyst Ratings
DateActionAnalystRatingTarget
May-07-26ReiteratedMizuho Securities$85 → $90
May-07-26ReiteratedBarclaysEqual Weight$67 → $76
Feb-25-26ReiteratedStifel NicolausBuy$70 → $80
Feb-25-26ReiteratedNeedhamBuy$88 → $81
Feb-19-26ReiteratedPiper SandlerOverweight$85
Jan-09-26ReiteratedGoldman SachsBuy$56 → $66
Jan-09-26ReiteratedBarclaysEqual Weight$56 → $67
Dec-19-25InitiatedKeyBancOverweight$81
Dec-17-25ReiteratedMizuho Securities$70 → $72
Dec-16-25ReiteratedRobert W. Baird$70 → $75
Latest News
Jun-17-26
Jun-17-2602:14PM
LivaNova Reports Improved OSA Outcomes With PolySync ProgrammingYahoo
Jun-16-26
Jun-16-2602:57PM
LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep ApneaYahoo
Jun-12-26
Jun-12-2611:09AM
LivaNova (LIVN) Stock Valuation Check After Strong Recent Shareholder ReturnsYahoo
Jun-11-26
Jun-11-2605:44PM
Jette Nygaard-Andersen Joins LivaNova Board as a New DirectorYahoo
Jun-10-26
Jun-10-2610:21PM
LivaNova: My Targets Hold, Maintaining My Rating For H2SeekingAlpha
11:42AM
LivaNova PLC (LIVN) Shareholder/Analyst Call Prepared Remarks TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,4341,3881,253
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A465448383
Gross Profit969940871
Selling, General and Administrative Excl. Other564549526
Research and Development197186183
Other Operating Expense5633
Operating Income203199129
Interest Expense514963
Unusual Expense
———
Non-Operating Income (Expense)30371-22
Net Income Before Taxes122-22188
Income Taxes142225
Consolidated Net Income107-24263
Net Income From Continuing Operations107-24263
Net Income107-24263
EPS (Recurring)1.97-4.451.17
EPS (Basic, Before Extraordinaries)1.97-4.451.17
EPS (Diluted)1.96-4.451.16
EBITDA216-129203
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
40.05——
Price To Sales Ratio3.012.44—
Gross Margin67.5767.7269.51
Operating Margin14.1614.3410.30
Net Margin7.46-17.445.03
Shares Outstanding555554
Market Capitalization4,3183,384—
Operating Lease Expense
———
Insider Trading Volume
$83.34$74.43$65.53$56.62$47.71● Close Price0.00K34.09K68.17K102.26K136.35KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
WILVER PETER MDirectorJun 15 '26Option Exercise0.008,084010,780Jun 17 12:00 AM
SCHERMERHORN TODD CDirectorJun 15 '26Option Exercise0.008,084013,105Jun 17 12:00 AM
Bianchi FrancescoDirectorJun 15 '26Option Exercise0.008,084011,270Jun 17 12:00 AM
Bianchi FrancescoDirectorJun 15 '26Sale80.191,20096,2289,584Jun 17 12:00 AM
PODLOGAR SUSAN MDirectorJun 15 '26Option Exercise0.008,08406,128Jun 17 12:00 AM
Barry James ChristopherDirectorJun 15 '26Option Exercise0.008,08408,404Jun 17 12:00 AM
Tezel AhmetChief Innovation OfficerJun 15 '26Option Exercise0.005,93007,122Jun 17 12:00 AM
KOZY WILLIAM ADirectorJun 15 '26Option Exercise0.0011,362038,248Jun 17 12:00 AM
Enxing Seng StacyDirectorJun 15 '26Option Exercise0.008,084015,793Jun 17 12:00 AM
Story BrookeDirectorJun 15 '26Option Exercise0.008,084010,274Jun 17 12:00 AM
Zurbay DonaldDirectorJun 15 '26Option Exercise0.005,12002,560Jun 17 12:00 AM
Bianchi FrancescoDirectorMay 26 '26Sale75.751,800136,3507,228May 27 12:00 AM
Tezel AhmetChief Innovation OfficerMar 30 '26Option Exercise0.006,81606,814Apr 01 12:00 AM
Poletti FrancoPresident, CardiopulmonaryMar 30 '26Option Exercise0.006,368012,125Apr 01 12:00 AM
Shvartsburg AlexChief Financial OfficerMar 30 '26Option Exercise0.0050,290057,515Apr 01 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR